Denosumab (Drug Plan Submission)


( Last Updated : March 10, 2015)
Generic Name:
Denosumab (Drug Plan Submission)
Project Status:
Complete
Therapeutic Area:
Osteoporosis, men
Manufacturer:
Amgen Canada
Call for patient/clinician input open:
Brand Name:
Prolia
Project Line:
Reimbursement Review
Project Number:
SR0414-000
Call for patient/clinician input closed:

Details


Submission Type:
Drug Plan Initiated
Indications:
Osteoporosis, men
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: